regulatoryaffairs.pharmaceuticalconferences.comRegulatoryaffairs-2022 | 10th International Conference on Pharmaceutical Regulatory Affairs and IPR

Toggle navigation MENU Regulatoryaffairs-2022 HomeJournals A-Z Journals Browse by Subject Newly Launched Journals Open Access Conferences Upcoming Conferences Previous Conferences Past Conferences Reports Abstract Registration Technical Program Symposium & Contact Details Scientific Program Call for Abstracts Brochure & Contact Details Organizing Committee Poster Submission Speaker Guidelines & FAQs Terms & Conditions B2B Venue & Hospitality Sponsors / Exhibitors Sponsors Exhibition Our Supporters 2024 Supporters 2023 Supporters 2022 Supporters 2021 Supporters 2020 Supporters 2019 Supporters 2018 Supporters 2017 Supporters 2016 Supporters 2015 Supporters 2014 Supporters 2013 Supporters 2012 Supporters 2011 Supporters Awards Research Excellence Awards Poster Presentation Young Researchers Forum ePoster Presentation 10 th International Conference on Pharmaceutical Regulatory Affairs and IPR April 13-14, 2022 Montreal, Canada Current challenges of Pharmaceutical & Biopharmaceutical Industries in regulatory framework Submit Abstract Register Now Sessions & Tracks Program Schedule Reader Base Awards Nomination Search 1000+ Events Abstract Submission Registration Organizing Committee Conference Brochure Sessions & Tracks Scientific Program Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business. Explore and learn more about Conference Series : World’s leading Event Organizer Conference Series Conferences gaining more Readers and Visitors Conference Series Web Metrics at a Glance 3000+ Global Events 100 Million+ Visitors 75000+ Unique visitors per conference 100000+ Page views for every individual conference Unique Opportunity! Online visibility to the Speakers and Experts Recommended Global Pharmaceutical Sciences Webinars & Conferences Europe & UK Asia Pacific & Middle East Canada Regulatoryaffairs-2022 Regulatory Affairs 2022 Sessions/Tracks Market Analysis Regulatory Affairs 2022 Details of Regulatory Affairs 2022 Conference in USA: Conference Name Place Date Regulatory Affairs 2022 Montreal, Canada April 13-14, 2022 With the coordination of renowned speakers of Regulatory Affairs 2018 Conference series LLC Ltd is privileged to announce "10th International Conference on Pharmaceutical Regulatory Affairs and IPR" which is slated on April 13-14, 2022 Montreal, Canada. We cordially invite all regulatory scientists, intellectual property rights (IPR) attorneys, pharmaceutical manufacturers, quality control analysts, quality assurance analysts, pharmaceutical auditors, clinical research associates in the fields of regulatory affairs, intellectual property rights, medical devices and Clinical research to contribute their role towards the conference by sharing their research work, new strategies in the fields. 2022 Key Themes Regulatory Affairs 20 22 conference will focus on new strategies, amendments, innovations, developments in the fields of regulatory affairs, intellectual property rights and medical devices with the theme: "Current challenges of Pharmaceutical & Biopharmaceutical Industries in regulatory framework& which reflects new strategies in the field of regulatory affairs. This conference includes workshops, symposiums, special sessions, key note sessions, conducted by eminent and renowned speakers who excel in the field of regulatory affairs, medical devices, intellectual property rights which include the topics Good Manufacturing Practices: The Gap Within, Regulatory Affairs, Pharmaceutical Audit, Current GMP Guidelines (cGMP) & GxP in Pharmaceuticals, Good Clinical Practices and Good Laboratory Practices, Current Regulations and Quality Standards, GMP in Food Industry, Microbiology & Biotechnology, Clinical Affairs & Regulatory Strategies, Penalties for Regulatory Non-compliance, Global Regulatory Intelligence, Impact of Brexit on Regulatory Framework, Regulatory Communications and Submissions, Regulatory Requirements for Pharmaceuticals, Regulatory Challenges for Medical Devices, Medical Device & Combination Products Regulations, Quality Control & Quality Assurance, Intellectual Property Rights, Best Industry Practices, Softwares in GMP and GCP, Excipient Qualification and Supply Chain Controls, Quality Management System in Testing Laboratories, Auditing Deviations, Product Complaints, and CAPA Systems,Validation etc. This International Regulatory Affairs Conference also encourages the active participation of Young Researchers, Students as we are hosting Poster Award Competition and Young Research Forum at the conference venue. Target Audience: Regulatory Affairs experts Clinical Research Associates Medical Devices experts Quality Assurance experts Intellectual Property Rights attorneys Scientists Researchers Academicians Industrialists Continent wise participation Analysis for Regulatory Affairs 2021 conference Sessions/Tracks Track 1: Good Manufacturing Practices: The Gap Within Good Manufacturing Practice is the part of quality management which ensures that products are consistently produced and controlled according to the quality standards appropriate to their intended use and as required by the marketing authorization, clinical trial authorization or product specification. Good Manufacturing practices conference aims at both production and Quality Control . Current Good Manufacturing Practices (cGMP) is aimed primarily at managing and minimizing the risks inherent in pharmaceutical manufacture to ensure the quality, safety and efficacy of products. FDA regulates the quality of pharmaceuticals very carefully. Current Trends in the FDA is the main regulatory standard for ensuring pharmaceutical quality . Track 2: Regulatory Affairs Regulatory Affairs profession was developed by the government regulatory bodies to regulate the safety and efficacy of products to protect the health of public. This was developed in all most all divisions of health care industry like pharmaceuticals , veterinary medicines, medical devices , pesticides, agrochemicals, cosmetics, complimentary medicines etc. This profession involves development of new and existing products from early on, preparation and till submission to the relevant regulatory bodies of health authorities by inputting regulatory principles. Regulatory Affairs is involved actively from early stage of development to post marketing activities of new and existing products. This department is one of the integral parts within the organization structure of pharmaceutical industry . Internally it collaborates at the interphase of drug development, manufacturing, marketing and clinical research. Externally it is the key interface between the commercial industry which undergoes drug development to clinical research and the regulatory authorities. Track 3: Pharma Audit The quality of pharmaceuticals has been a concern of the World Health Organization (WHO) since its inception. The setting of global standards is requested in Article 2 of the WHO Constitution, which cites as one of the Organization’s functions that it should develop, establish and promote international standards with respect to food, biological, pharmaceutical and similar products.” Quality Assurance (QA) and independent audit is critical in the pharmaceutical industry to assure reliability of the products, adherence to approved specifications, and conformation of current good manufacturing practices (cGMP) to regulation. Manufacturers must establish a quality control unit that is responsible for quality-related activities required by the regulations. Quality is determined by whether the firm complies with GMP requirements and makes scientifically justified decisions. Pharmaceutical companies are now taking a proactive stance with the new GMP Systems approach, more effective internal auditing and increased regulatory awareness throughout the company. Track-4: Current GMP Guidelines (cGMP) & GxP in...